Myeloid neighborhood in myeloma: Cancer's underbelly?

American Journal of Hematology

Volumn 84, Issue 7, 2009, Pages 395-396

  Dhodapkar, Madhav V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; CELL DEATH; CELL FUSION; CELL INFILTRATION; CELL SURVIVAL; CELL TYPE; DENDRITIC CELL; HUMAN; MYELOMA; NOTE; OSTEOCLAST; PLASMACYTOMA; PRIORITY JOURNAL; TUMOR GROWTH;

HUMANS; MULTIPLE MYELOMA; MYELOID CELLS; PLASMACYTOMA;

EID: 67649729605     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21460     Document Type: Note

References (17)

1. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1: 46-54. (Pubitemid 33741880)
2. Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-266. (Pubitemid 43121975)
3. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997;276:1851-1854. (Pubitemid 27443660)
4. Said JW, Rettig MR, Heppner K, et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997;90:4278-4282. (Pubitemid 27508433)
5. Chauhan D, Bharti A, Raje N, et al. Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood 1999;93:1482-1486. (Pubitemid 29102473)
6. Podar K, Richardson PG, Hideshima T, et al. The malignant clone and the bone-marrow environment. Best Pract Res Clin Haematol 2007;20:597-612. (Pubitemid 350215375)
7. Peng KW, Vrana J, Liu C, et al. Tumor associated macrophages infiltrate plasmacytomas and can serve as carriers of virotherapy of disseminated myeloma. Am J Hematol 2009.
8. Kukreja A, Hutchinson A, Dhodapkar K, et al. Enhancement of clonogenicity of human multiple myeloma by dendritic cells. J Exp Med 2006;203:1859-1865. (Pubitemid 44188460)
9. Kukreja A, Hutchinson A, Mazumder A, et al. Bortezomib disrupts tumourdendritic cell interactions in myeloma and lymphoma: Therapeutic implications. Br J Haematol 2007;136:106-110. (Pubitemid 44912594)
10. Bahlis NJ, King AM, Kolonias D, et al. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood 2007;109:5002-5010. (Pubitemid 46827800)
11. Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002;99:1745-1757. (Pubitemid 34533050)
12. Dhodapkar MV, Dhodapkar KM, Palucka AK. Interactions of tumor cells with dendritic cells: Balancing immunity and tolerance. Cell Death Differ 2008;15: 39-50. (Pubitemid 350286171)
13. Conejo-Garcia JR, Benencia F, Courreges MC, et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 2004;10:950-958. (Pubitemid 39273736)
14. Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma: Implications and significance. Blood 2005;105:3286-3294. (Pubitemid 40504351)
15. Corthay A, Skovseth DK, Lundin KU, et al. Primary antitumor immune response mediated by CD41 T cells. Immunity 2005;22:371-383. (Pubitemid 40387478)
16. Pawelek JM, Chakraborty AK. The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res 2008;101:397-444.
17. Lewis C, Murdoch C. Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies. Am J Pathol 2005;167:627-635. (Pubitemid 41216349)